CH575380A5 - - Google Patents

Info

Publication number
CH575380A5
CH575380A5 CH983473A CH983473A CH575380A5 CH 575380 A5 CH575380 A5 CH 575380A5 CH 983473 A CH983473 A CH 983473A CH 983473 A CH983473 A CH 983473A CH 575380 A5 CH575380 A5 CH 575380A5
Authority
CH
Switzerland
Application number
CH983473A
Original Assignee
Centre Etd Ind Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Etd Ind Pharma filed Critical Centre Etd Ind Pharma
Publication of CH575380A5 publication Critical patent/CH575380A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH983473A 1972-07-20 1973-07-05 CH575380A5 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7226158A FR2192811B1 (xx) 1972-07-20 1972-07-20

Publications (1)

Publication Number Publication Date
CH575380A5 true CH575380A5 (xx) 1976-05-14

Family

ID=9102125

Family Applications (1)

Application Number Title Priority Date Filing Date
CH983473A CH575380A5 (xx) 1972-07-20 1973-07-05

Country Status (11)

Country Link
US (1) US3906030A (xx)
JP (1) JPS5720938B2 (xx)
AR (1) AR205520A1 (xx)
BE (1) BE802066A (xx)
CA (1) CA989838A (xx)
CH (1) CH575380A5 (xx)
DE (1) DE2336670A1 (xx)
ES (1) ES417042A1 (xx)
FR (1) FR2192811B1 (xx)
GB (1) GB1383888A (xx)
ZA (1) ZA734675B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54119428A (en) * 1978-02-24 1979-09-17 Hisamitsu Pharmaceut Co Inc Novel benzoic acid derivative
FR2581643B1 (fr) * 1985-05-10 1988-11-18 Irceba Compositions pharmaceutiques utiles dans le domaine de l'urologie, contenant de l'acetoxy-1 methyl-2 ((piperidino)-2 ethoxy)-4 (methyl-1 ethyl)-5 benzene ou l'un de ses sels
FR2594122B1 (fr) * 1986-02-10 1988-06-10 Irceba ((pyrrolidinyl-1)-2 ethyoxy)-3 p cymene, les derives acetyl, acetoxy, hydroxy dudit produit et les medicaments contenant lesdits composes comme principe actif
FR2614302B2 (fr) * 1986-02-10 1989-07-28 Irceba Derives du ((pyrrolidinul-1)-2 ethoxy)-5 p-cymene, procede pour leur preparation et medicaments en contenant.
FR2595357B1 (fr) * 1986-03-04 1988-07-08 Irceba (piperidino-3 propoxy)-5 p.cymene, les derives acetyl, acetoxy et hydroxy dudit produit, les sels de ces produits, un procede de preparation desdits produits et les medicaments contenant au moins un de ces produits comme principe actif
DE3778152D1 (de) * 1987-04-30 1992-05-14 Inst Rech Chim Biolog Derivate von 5-(2-(1-pyrrolidinyl)-aethoxy)-p-cymen, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittel.
JP4799872B2 (ja) * 2004-03-31 2011-10-26 株式会社アクティバスファーマ ４級アンモニウム化合物、その製造方法及び脳血管障害治療剤
TWI356054B (en) * 2004-03-31 2012-01-11 Activus Pharma Co Ltd Quaternary ammonium compound, producing method the

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1118219B (de) * 1957-02-21 1961-11-30 Bayer Ag Verfahren zur Herstellung von basisch substituierten Alkylaethern von o-Kresotinsaeureestern und deren Salzen

Also Published As

Publication number Publication date
FR2192811B1 (xx) 1975-08-08
GB1383888A (en) 1974-02-12
ES417042A1 (es) 1976-03-01
DE2336670A1 (de) 1974-01-31
FR2192811A1 (xx) 1974-02-15
JPS5720938B2 (xx) 1982-05-04
US3906030A (en) 1975-09-16
CA989838A (en) 1976-05-25
AR205520A1 (es) 1976-05-14
ZA734675B (en) 1974-06-26
BE802066A (fr) 1973-11-05
JPS4943936A (xx) 1974-04-25

Similar Documents

Publication Publication Date Title
FR2189200B1 (xx)
FR2169266A1 (xx)
FR2170169A1 (xx)
FR2192811B1 (xx)
FR2192813B1 (xx)
IN140547B (xx)
JPS4897155A (xx)
JPS4934411A (xx)
JPS4948948A (xx)
JPS4881956A (xx)
JPS4963936A (xx)
JPS5135025Y2 (xx)
JPS5436409Y2 (xx)
JPS5512992B2 (xx)
JPS5231007B2 (xx)
JPS5442247B2 (xx)
JPS48103815U (xx)
CH561600A5 (xx)
BG21231A3 (xx)
CH560979A5 (xx)
CH565149A5 (xx)
CH569108A5 (xx)
CH583192A5 (xx)
BG21010A3 (xx)
CH565145A5 (xx)

Legal Events

Date Code Title Description
PL Patent ceased